The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis.
Open accessAbstract
Recent studies have shown that mucocutaneous leishmaniasis (MCL), a severe and debilitating form of American cutaneous leishmaniasis (ACL) caused by Leishmania braziliensis infection, is accompanied by high circulating levels of tumor necrosis factor (TNF)-alpha. Analysis of TNF polymorphisms in Venezuelan ACL patients and endemic unaffected controls demonstrates a high relative risk (RR) of 7.5 (P < 0.001) of MCL disease in homozygotes for allele 2 of a polymorphism in intron 2 of the TNF-beta gene, especially in females (RR = 9.5; P < 0.001) compared with males (RR = 4; P < 0.05). A significantly higher frequency (P < 0.05) of allele 2 at the -308-basepair TNF-alpha gene polymorphism was also observed in MCL patients (0.18) compared with endemic control subjects (0.069), again associated with a high relative risk of disease (RR = 3.5; P < 0.05) even in the heterozygous condition. Because both the TNF-alpha and TNF-beta polymorphisms have previously been linked with functional differences in TNF-alpha levels, these data suggest that susceptibility to the mucocutaneous form of disease may be directly associated with regulatory polymorphisms affecting TNF-alpha production.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Human Genetic Linkage.
Edwards, A. W. F., & Ott, J. (1992) · Biometrics · doi:10.2307/2532370 · Cited by 1,691
Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria
McGuire, W., Hill, A. V. S., Allsopp, C. E. M., Greenwood, B. M., & Kwiatkowski, D. (1994) · Nature · doi:10.1038/371508a0 · Cited by 1,169
Wilson, A. G., di Giovine, F. S., Blakemore, A. I. F., & Duff, G. W. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.5.353 · Cited by 881
Analysis of Human Genetic Linkage.
Edwards, A. W. F., & Ott, J. (1987) · Biometrics · doi:10.2307/2531972 · Cited by 699
Jacob, C. O., Fronek, Z., Lewis, G. D., Koo, M., Hansen, J. A., & McDevitt, H. O. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.3.1233 · Cited by 627
Analysis of Human Genetic Linkage
Read, A. P. (1992) · Journal of Medical Genetics · doi:10.1136/jmg.29.9.680 · Cited by 623
Pociot, F., Briant, L., Jongeneel, C. V., Mölvig, J., Worsaae, H., Abbal, M., Thomsen, M., Nerup, J., & Cambon‐Thomsen, A. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230135 · Cited by 548
Messer, G., Spengler, U., Jung, M. C., Honold, G., Blömer, K., Pape, G. R., Riethmüller, G., & Weiss, E. H. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.1.209 · Cited by 543
Cytokine patterns in the pathogenesis of human leishmaniasis.
Pirmez, C., Yamamura, M., Uyemura, K., Paes-Oliveira, M., Conceição-Silva, F., & Modlin, R. L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116341 · Cited by 364
Genomic structure and function in the MHC
Trowsdale, J. (1993) · Trends in Genetics · doi:10.1016/0168-9525(93)90205-v · Cited by 188
Cited by
Fishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V, Yudkin, J. S., Humphries, S., & Woo, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2629 · Cited by 2,243
“There is a strong association between a worse outcome from malaria or mucocutaneous leishmaniasis and the rare allele of the 2308 TNF-a promoter polymorphism (TNFA2) (24, 25).”
BackgroundWilson, A. G., Symons, J. A., McDowell, T. L., McDevitt, H. O., & Duff, G. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3195 · Cited by 2,218
Murray, H. W., Berman, J. D., Davies, C. R., & Saravia, N. G. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67629-5 · Cited by 1,771
Herwaldt, B. L. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10178-2 · Cited by 1,229
Cytokine gene polymorphism in human disease: on-line databases
Bidwell, J., Keen, L., Gallagher, G., Kimberly, R., Huizinga, T., McDermott, M., Oksenberg, J., McNicholl, J., Pociot, F., Hardt, C., et al. (1999) · Genes & Immunity · doi:10.1038/sj.gene.6363645 · Cited by 812
THE IMMUNOGENETICS OF HUMAN INFECTIOUS DISEASES
Hill, A. V. S. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.593 · Cited by 581
Louis, E., Franchimont, D., Piron, A., Gevaert, Y., Schaaf-Lafontaine, N., Roland, S., Mahieu, P., Malaise, M., De Groote, D., Louis, R., et al. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1998.00662.x · Cited by 575
Price, P., Witt, C., Allock, R., Sayer, D., Garlepp, M., Kok, C. C., French, M., Mallal, S., & Christiansen, F. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01398.x · Cited by 536
Blackwell, J. M., Jamieson, S. E., & Burgner, D. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00048-08 · Cited by 505
Self-citationKnight, J. C., Udalova, I., Hill, A. V. S., Greenwood, B. M., Peshu, N., Marsh, K., & Kwiatkowski, D. (1999) · Nature Genetics · doi:10.1038/9649 · Cited by 480
A Novel Polymorphism in the MCP-1 Gene Regulatory Region That Influences MCP-1 Expression
Rovin, B. H., Lu, L., & Saxena, R. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0796 · Cited by 456
BOUMA, G., CRUSIUS, J. B. A., OUDKERK POOL, M., KOLKMAN, J. J., VON BLOMBERG, B. M. E., KOSTENSE, P. J., GIPHART, M. J., SCHREUDER, G. M. T., MEUWISSEN, S. G. M., & PEÑA, A. S. (1996) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1996.d01-65.x · Cited by 373
Abraham, L. J., & Kroeger, K. M. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.4.562 · Cited by 368
Hoffmann, S. C., Stanley, E. M., Darrin Cox, E., Craighead, N., DiMercurio, B. S., Koziol, D. E., Harlan, D. M., Kirk, A. D., & Blair, P. J. (2001) · Transplantation · doi:10.1097/00007890-200110270-00019 · Cited by 341
Skoog, T., van't Hooft, F. M., Kallin, B., Jovinge, S., Boquist, S., Nilsson, J., Eriksson, P., & Hamsten, A. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.8.1443 · Cited by 313
Macones, G. A., Parry, S., Elkousy, M., Clothier, B., Ural, S. H., & Strauss, J. F. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.01.001 · Cited by 303
The role of TNF and its receptors in Alzheimer's disease
Perry, R. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00291-3 · Cited by 297
Immunopathogenesis of infection with the visceralizing Leishmania species
Wilson, M. E., Jeronimo, S. M. B., & Pearson, R. D. (2005) · Microbial Pathogenesis · doi:10.1016/j.micpath.2004.11.002 · Cited by 281
Salvi, G. E., Yalda, B., Collins, J. G., Jones, B. H., Smith, F. W., Arnold, R. R., & Offenbacher, S. (1997) · Journal of Periodontology · doi:10.1902/jop.1997.68.2.127 · Cited by 280
TNF-? gene polymorphism: Clinical and biological implications
Hajeer, A. H., & Hutchinson, I. V. (2000) · Microscopy Research and Technique · doi:10.1002/1097-0029(20000801)50:3<216::aid-jemt5>3.0.co;2-q · Cited by 274
The Genomics and Genetics of Human Infectious Disease Susceptibility
Hill, A. V. S. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.373 · Cited by 264
Is there a future for TNF promoter polymorphisms?
Bayley, J.-P., Ottenhoff, T. H. M., & Verweij, C. L. (2004) · Genes & Immunity · doi:10.1038/sj.gene.6364055 · Cited by 262
Genetic variation associated with preterm birth: a HuGE review
Crider, K. S., Whitehead, N., & Buus, R. M. (2005) · Genetics in Medicine · doi:10.1097/01.gim.0000187223.69947.db · Cited by 190
Blackwell, J. M. (1996) · Molecular Medicine Today · doi:10.1016/1357-4310(96)88773-9 · Cited by 97
Self-citation
Metadata
- Authors
- Cabrera, M., Shaw, M. A., Sharples, C., Williams, H., Castes, M., Convit, J., & Blackwell, J. M.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1995-11-01
- Volume
- 182
- Issue
- 5
- Pages
- 1259-1264
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2158116803
- Cited by
- 452
- References
- 14
- FWCI
- 24.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.